Pancreatic Cancer, Research and Clinical Trials

Meet the investigator: Daniel D. Billadeau, Ph.D.

By Nicole Ferrara • December 11, 2019
Estimated reading time: 1 minute

At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue, Daniel D. Billadeau, Ph.D., an oncology researcher at Mayo Clinic in Rochester, Minnesota, talks about his work investigating pancreatic cancer. Dr. Billadeau is also a principal investigator of the Mayo Clinic Pancreatic Cancer SPORE.

Related

This article was originally published in Forefront, Mayo Clinic Cancer Center's online magazine, which ceased publication in December 2020.

cancer pancreatic cancer Pancreatic Cancer research Research and Clinical Trials SPORE
Subscribe
Request an Appointment
Find a Clinical Trial
Predicting pancreatic cancer outcomes prior to surgery

Researchers demonstrated a way to predict survival outcomes for people with borderline resectable or locally advanced pancreatic cancer.

‘My life is in the right hands.’ Surgery gives California woman hope after cancer diagnosis

Vishakha Majithia's story of pancreatic cancer treatment at Mayo Clinic and surviving to hold her first grandchild.

Dear Mayo Clinic: Pancreatic cancer risk, symptoms and treatment

Dr. Mark Truty explains the risk factors and symptoms of pancreatic cancer and how it is diagnosed and treated.